Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.22NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.258.22NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.258.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.22NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AG.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AG.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AG.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AG.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.258.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.16NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.258.16NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.258.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.16NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
W.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
W.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
W.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
W.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
W.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.264.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.264.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.264.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.264.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.264.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BY.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BY.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.11.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.11.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.11.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.63NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.63NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FM.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FM.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.4.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.10.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used